6 studies found for: "Spinal Muscular Atrophy Type 2"
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
|2||Active, not recruiting||
Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.
Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)
Pilot Study of Growth Hormon to Treat SMA Typ II and III
Motor Development and Orthoses in Spinal Muscular Atrophy (SMA)
A Pilot Study of Biomarkers for Spinal Muscular Atrophy
† Indicates status has not been verified in more than two years